In a similar study, newly diagnosed AML patients (n = 23) had a higher frequency of TIGIT+PD-1+TIM3+ NK cells compared to normal subjects, which was associated with poor prognosis. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.